Literature DB >> 16827731

Periodontal pathogens in atheromatous plaques isolated from patients with chronic periodontitis.

C Padilla1, O Lobos, E Hubert, C González, S Matus, M Pereira, S Hasbun, C Descouvieres.   

Abstract

BACKGROUND AND
OBJECTIVE: It has been suggested that chronic infections may predispose to cardiovascular disease. The relationship between periodontal disease and cardiovascular disease has been a subject of increasing research in recent years. The isolation and identification of periodontal bacteria from atheromatous plaque can contribute to our knowledge of this vascular disease. The aim of this study was to isolate and identify periodontal bacteria from the periodontal pockets of different patients and to compare them with the microorganisms detected in the atheromatous plaques obtained from the same patients.
MATERIAL AND METHODS: Clinical isolates were obtained from 12 patients with periodontal wounds and atheromathous plaques. These samples were cultured in the appropriate bacteriological culture media and incubated in an anaerobic system. Periodontal bacteria were identified using polymerase chain reaction (PCR) assays.
RESULTS: From the 12 patients studied, nine presented different periodontopathic bacterial species. In two, Actinobacillus actinomycetemcomitans was present in the periodontal pockets and the respective atheromatous plaques.
CONCLUSION: The presence of A. actinomycetemcomitans in atheromatous plaques and the periodontal pockets of the same patients could indicate a role for periodontal pathogenic bacteria in the atherosclerosis disease process.

Entities:  

Mesh:

Year:  2006        PMID: 16827731     DOI: 10.1111/j.1600-0765.2006.00882.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  40 in total

Review 1.  Infection and Atherosclerosis Development.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Arch Med Res       Date:  2015-05-21       Impact factor: 2.235

Review 2.  Bacterial invasion of vascular cell types: vascular infectology and atherogenesis.

Authors:  Emil Kozarov
Journal:  Future Cardiol       Date:  2012-01

3.  Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice.

Authors:  Chie Hayashi; Jason Viereck; Ning Hua; Alkystis Phinikaridou; Andrés G Madrigal; Frank C Gibson; James A Hamilton; Caroline A Genco
Journal:  Atherosclerosis       Date:  2010-12-22       Impact factor: 5.162

4.  Acanthoic acid inhibits LPS-induced inflammatory response in human gingival fibroblasts.

Authors:  Cai Wei; Chee Keong Tan; He Xiaoping; Jiang Junqiang
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

Review 5.  Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways.

Authors:  C Hayashi; C V Gudino; F C Gibson; C A Genco
Journal:  Mol Oral Microbiol       Date:  2010-10       Impact factor: 3.563

6.  The in vivo T helper type 17 and regulatory T cell immune responses to Aggregatibacter actinomycetemcomitans.

Authors:  S Mahabady; N Tjokro; S Aharonian; H H Zadeh; C Chen; H Allayee; P P Sedghizadeh
Journal:  Mol Oral Microbiol       Date:  2017-06-27       Impact factor: 3.563

7.  Helicobacter pylori vs coronary heart disease - searching for connections.

Authors:  Magdalena Chmiela; Adrian Gajewski; Karolina Rudnicka
Journal:  World J Cardiol       Date:  2015-04-26

8.  Association of serum immunoglobulin G (IgG) levels against two periodontal pathogens and prothrombotic state: a clinical pilot study.

Authors:  Sergio Bizzarro; Elena A Nicu; Ubele van der Velden; Marja L Laine; Bruno G Loos
Journal:  Thromb J       Date:  2010-11-04

9.  Effects of age and oral disease on systemic inflammatory and immune parameters in nonhuman primates.

Authors:  J L Ebersole; M J Steffen; J Gonzalez-Martinez; M J Novak
Journal:  Clin Vaccine Immunol       Date:  2008-04-30

Review 10.  The microbiome in autoimmune rheumatic disease.

Authors:  Maximilian F Konig
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-02-07       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.